SCHEMBL1817804

SCHEMBL1817804

CN(C)c1nc(N(C)CO)nc(N(C)CO)n1

nearest known ligand 0.58

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.58
CYP1A2 P05177 1/20 0.58
THRB P10828 1/20 0.58
BLM P54132 1/20 0.58
CREBBP Q92793 1/20 0.58
HSD17B10 Q99714 1/20 0.58
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 2/20 0.40
HTT P42858 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1309901 1.00 LMNA (0.58) LMNACYP1A2THRBBLMCREBBP
Trimelamol SCHEMBL1419460 0.92 LMNA (0.42) LMNACYP1A2THRBBLMCREBBP
SCHEMBL3115681 0.91 LMNA (0.48) LMNACYP1A2THRBBLMCREBBP
SCHEMBL27649444 0.89 LMNA (0.46) LMNACYP1A2THRBBLMCREBBP
SCHEMBL12610491 0.82 LMNA (0.35) LMNACYP1A2THRBBLMCREBBP
SCHEMBL13562967 0.82 LMNA (0.35) LMNACYP1A2THRBBLMCREBBP
SCHEMBL11764977 0.80 LMNA (0.52) LMNACYP1A2THRBBLMCREBBP
SCHEMBL11772001 0.80 LMNA (0.52) LMNACYP1A2THRBBLMCREBBP
SCHEMBL22058984 0.79 LMNA (0.58) LMNACYP1A2THRBBLMCREBBP
SCHEMBL19272104 0.79 LMNA (0.58) LMNACYP1A2THRBBLMCREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10429753-B2 Electrophotographic photoconductor, process cartridge, and electrophotographic apparatus CANON KABUSHIKI KAISHA (JP) 2019-10-01 US disclosed
EP-2504320-B1 Melamine based mannich-compounds and a process for obtaining the same BOREALIS AGROLINZ MELAMINE (AT) 2015-10-14 EP disclosed
CN-102648187-B Melamine-based mannich compounds and method for obtaining same BOREALIS AGROLINZ MELAMINE 2015-06-03 CN disclosed
US-8802848-B2 Melamine based mannich-compounds and a process for obtaining the same BOREALIS AGROLINZ MELAMINE GMBH (AT) 2014-08-12 US disclosed
US-20120277429-A1 Melamine Based Mannich-Compounds and a Process for Obtaining the Same BOREALIS AGROLINZ MELAMINE GMBH (AT) 2012-11-01 US disclosed
EP-2504320-A1 MELAMINE BASED MANNICH-COMPOUNDS AND A PROCESS FOR OBTAINING THE SAME Borealis Agrolinz Melamine GmbH (AT) 2012-10-03 EP disclosed
WO-2011061220-A1 MELAMINE BASED MANNICH-COMPOUNDS AND A PROCESS FOR OBTAINING THE SAME BOREALIS AGROLINZ MELAMINE GMBH (AT) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277429-A1 Melamine Based Mannich-Compounds and a Process for Obtaining the Same MAN2A1, MANBA, MAN2B2 LMNA 297/4885CYP1A2 332/4885THRB 3586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.